GlassScriptPhysician profile
Michael Romilos Barnett
NPI 1023003555
$666.80
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $180 · 2022: $40.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $93.79 | 2019 | |
| Allergan, INC. | $71.31 | 2019-2020 | |
| Abbvie INC. | $65.26 | 2019-2020 | |
| Daiichi Sankyo INC. | $63.40 | 2020 | |
| Coopersurgical, INC. | $56.90 | 2019-2020 | |
| Pfizer INC. | $54.05 | 2019-2020 | |
| Medtronic, INC. | $40.00 | 2022 | |
| Millicent US INC | $34.95 | 2019-2020 | |
| Amgen INC. | $34.66 | 2019 | |
| Avion Pharmaceuticals | $28.30 | 2019-2020 | |
| Astellas Pharma US INC | $23.15 | 2019 | |
| Ethicon US, LLC | $23.12 | 2019 | |
| Therapeuticsmd, INC. | $17.15 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.47 | 2019 | |
| Aspira Women'S Health INC | $16.05 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.61 | 2020 | |
| Merck Sharp & Dohme LLC | $13.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.